STOCKHOLDERS' EQUITY

9 Months Ended

Sep. 30, 2018

STOCKHOLDERS’ EQUITY

Dividends

The following table summarizes the Company’s cash dividend activity for the nine months ended September 30, 2018 (in thousands, except per share data):



Declaration Date	Per Share		Amount		Record Date	Payment Date
July 18, 2018 (special)	$	0.25	$	2,844	August 14, 2018	August 24, 2018
July 18, 2018	0.15		1,707		August 14, 2018	August 24, 2018
April 17, 2018 (special)	1.76		20,022		May 15, 2018	May 25, 2018
April 17, 2018	0.14		1,592		May 15, 2018	May 25, 2018
February 6, 2018	0.13		1,479		February 27, 2018	March 9, 2018
	$	2.43	$	27,644

Declaration and payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors.

Stock Repurchases

On January 12, 2016, the Board of Directors authorized an increase to the Company’s stock repurchase program first approved on July 28, 2015 from $15.0 million to $70.0 million. Repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. For all or a portion of the authorized repurchase amount, the Company may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The stock repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued. As of September 30, 2018, $32.0 million of the $70.0 million stock repurchase program approved on July 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of related estimated income tax.

Restricted Stock

No stock-based compensation was recognized for the three or nine months ended September 30, 2018. Stock-based compensation expense totaled $8,600 and $25,900 for the three and nine months ended September 30, 2017, respectively.

At the Company’s annual meeting of stockholders held on April 7, 2016, the Company’s stockholders approved the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “2016 Plan”) to replace its 2007 Equity Incentive Plan. The 2016 Plan allows for the grant of various equity awards including incentive stock options, non-statutory options, stock, stock units, stock appreciation rights and other similar equity-based awards to the Company’s employees, officers, non-employee directors, contractors, consultants and advisors of the Company. Up to 2,500,000 shares of the Company’s common stock (subject to adjustment under certain circumstances) may be issued pursuant to awards granted. At September 30, 2018, 2,359,671 shares remained available for issuance under the 2016 Plan.

On February 1, 2018, the Company granted 34,202 shares of restricted common stock under the 2016 Plan to certain employees for the purpose of further aligning their interest with those of its stockholders and settling fiscal 2017 performance incentives totaling $554,000. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances.

The following table summarizes the Company’s restricted stock activity under the 2016 Plan:



	Shares		Wtd. Avg. Price at Date of Issuance
Nonvested at December 31, 2017	58,032		$	28.59
Granted	34,202		16.19
Vested	(35,061	)	26.31
Nonvested at September 30, 2018	57,173		22.57

Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss by component for the first nine months of 2018 were as follows (in thousands):



	Foreign Currency Translation Adjustment			Unrealized Gains/(Losses) on Available-For-Sale Investments			Total
Balance, December 31, 2017	$	(386	)	$	(27	)	$	(413	)
Other comprehensive income (loss)	(798		)	9			(789		)
Balance, September 30, 2018	$	(1,184	)	$	(18	)	$	(1,202	)